Please assess the completion status of the following clinical trial:

Trial Title: Safety and Preliminary Efficacy Study of V404 PDS in Uveitis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE1/PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* 18 years of age or older~* Confirmed diagnosis of active uveitis~* Sufficient lens/media clarity~* Meet best-corrected visual acuity criteria~* Willing and able to use contraception~Exclusion Criteria:~* Pregnant, breast feeding~* Uncontrolled glaucoma~* Intraocular surgery or periocular/intraocular injections within 6 weeks~* Periocular or intraocular steroid within 3 months~* Prior vitrectomy~* Prior corneal transplant~* Prior fluocinolone implant~* Allergy or sensitivity to study drug~* Participation in other trial within 30 days~* Abnormal liver function~* History of positive serum tuberculosis test

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Low Dose V404 PDS (Type: EXPERIMENTAL): Sustained intravitreal delivery of methotrexate (0.6 mg)
- High Dose V404 PDS (Type: EXPERIMENTAL): Sustained intravitreal delivery of methotrexate (2.3 mg)

Based on this trial design, predict the completion outcome and termination type (if applicable).